The highest concentration of IL17A and IL33 was in the 60–69 age group of colon cancer subjects, with significant difference in these IL concentrations between the 60–69 age group and the other age groups (see Figure 5 and Table 1). This evidence concerns the gene IL33 and malignant colon neoplasm.